Loading clinical trials...
Loading clinical trials...
A Phase I Trial of CC-5013 (Lenalidomide) in Pediatric Patients With Recurrent or Refractory Primary CNS Tumors
Conditions
Interventions
lenalidomide
perfusion-weighted magnetic resonance imaging
+2 more
Locations
1
United States
Pediatric Brain Tumor Consortium
Memphis, Tennessee, United States
Start Date
November 1, 2004
Primary Completion Date
November 1, 2010
Last Updated
September 30, 2013
NCT02684071
NCT02194452
NCT00326664
NCT00063973
NCT00281944
NCT01076530
Lead Sponsor
National Cancer Institute (NCI)
Data Source & Attribution
This clinical trial information is sourced from ClinicalTrials.gov, a service of the U.S. National Institutes of Health.
Modifications: This data has been reformatted for display purposes. Eligibility criteria have been parsed into inclusion/exclusion sections. Location data has been geocoded to enable distance-based search. For the authoritative and most current information, please visit ClinicalTrials.gov.
Neither the United States Government nor Clareo Health make any warranties regarding the data. Check ClinicalTrials.gov frequently for updates.
View ClinicalTrials.gov Terms and Conditions